spacer
home > ict > autumn 2018 > streamlining start-ups
PUBLICATIONS
International Clinical Trials

Streamlining Start-Ups

New life sciences industry research reveals significant momentum towards streamlining clinical systems and processes over the past year. More than 300 clinical operations professionals from around the globe were surveyed in an annual unified clinical operations survey to track the industry’s progress in improving clinical operations. Nearly all clinical leaders (99%) recognise the need to unify their clinical operating environments, and most (87%) have plans in place to get there.

Better Visibility and Faster Trial Execution

The widespread move to unify clinical environments is being driven by application and process silos that have resulted from the steady adoption of function-specific clinical technologies over the past decade. Stand-alone eClinical applications, including electronic data capture, electronic trial master files (eTMFs), randomisation and trial supply management, and clinical trial management systems (CTMSs) are now the norm. Newer, purpose-built applications, such as study start-up, are gaining traction (1).

Faced with a landscape of disparate systems and processes, over three quarters (77%) of those surveyed find better visibility across their clinical trial processes a top driver for unifying clinical applications. Other primary drivers include faster study execution (67%), improved study quality (62%), and increased productivity (51%).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Rik Van Mol is Vice President of R&D Strategy at Veeva Systems, responsible for the Veeva Vault R&D suite of applications in Europe. Rik has nearly 20 years of experience in business/IT consulting and has regulated content management in the life sciences sector. His experience has been built on assisting clients through complex transformational programmes across the life sciences value chain, including clinical, regulatory, and manufacturing/supply chain areas for some of the world’s largest companies.
spacer
Rik Van Mol
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Introduces Parteck® COAT Excipient, a Fast-Dissolving Material for Immediate Release Coating

• Designed to simplify the formulation and coating process for tablets • Optimized particle size leads to fast dissolving and increases coating process efficiency Merck has launched its Parteck® COAT excipient, a new functional material designed for immediate release film coating applications. Parteck® COAT is a particle engineered polyvinyl alcohol (PVA) with a unique particle structure that enables rapid dissolution even at low temperatures leading to an increased process efficiency.
More info >>

White Papers
 
Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement